80 Mg Tagrisso Osimertinib Tablet

Get a Price/Quote

80 Mg Tagrisso Osimertinib Tablet Specification

Dosage Form
Tablets

Drug Type
General Medicines

Physical Form
Tablets

Dosage
80 mg

Storage Instructions
Dry And Cool Place

80 Mg Tagrisso Osimertinib Tablet Trade Information

Minimum Order Quantity
1 Box

Supply Ability
10 Boxes Per Week

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About 80 Mg Tagrisso Osimertinib Tablet

80 Mg Tagrisso Osimertinib Tablet is a type of general medicine that comes in tablet form with a dosage of 80 mg. This medication is used to treat non-small cell lung cancer that has spread to other parts of the body. It works by blocking the activity of proteins that help cancer cells grow and divide, thus slowing down or stopping cancer growth. This medication is recommended to be stored in a dry and cool place to maintain its effectiveness.

FAQs of 80 Mg Tagrisso Osimertinib Tablet:

Q: How should I take this medication?

A: This medication should be taken orally with or without food, as directed by your doctor.

Q: What should I do if I miss a dose?

A: If you miss a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and resume your regular dosing schedule.

Q: What are the possible side effects of this medication?

A: The possible side effects of this medication include diarrhea, nausea, vomiting, loss of appetite, headache, rash, and breathing problems. Contact your doctor immediately if you experience any severe side effects.

Q: Can I drink alcohol while taking this medication?

A: It is not recommended to drink alcohol while taking this medication, as it may increase the risk of side effects.

Q: Is this medication safe during pregnancy?

A: This medication should not be used during pregnancy, as it may harm the developing fetus. It is important to use effective birth control while taking this medication and for at least 6 months after treatment ends.